Have a feature idea you'd love to see implemented?
Let us know!
STXS Stereotaxis Inc
Price (delayed)
$1.925
Market cap
$162.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.26
Enterprise value
$153.08M
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic
Highlights
Stereotaxis's debt has decreased by 7% YoY
STXS's gross margin is up by 7% QoQ and by 2.8% YoY
STXS's equity is down by 47% year-on-year and by 22% since the previous quarter
STXS's quick ratio is down by 31% YoY and by 16% QoQ
Key stats
What are the main financial stats of STXS
Market
Valuations
Earnings
Shares outstanding
84.66M
Market cap
$162.96M
Enterprise value
$153.08M
Price to earnings (P/E)
N/A
Price to book (P/B)
14.01
Price to sales (P/S)
6.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.45
Revenue
$23.75M
EBIT
-$20.75M
EBITDA
-$20.17M
Free cash flow
-$8.87M
Per share
Balance sheet
Liquidity
EPS
-$0.26
Free cash flow per share
-$0.1
Book value per share
$0.14
Revenue per share
$0.28
TBVPS
$0.43
Total assets
$36.01M
Total liabilities
$19.25M
Debt
$5.28M
Equity
$11.36M
Working capital
$15.82M
Debt to equity
0.47
Current ratio
2.29
Quick ratio
1.46
Net debt/EBITDA
0.49
Margins
Efficiency
Dividend
EBITDA margin
-84.9%
Gross margin
59.3%
Net margin
-87.4%
Operating margin
-91.4%
Return on assets
-54.6%
Return on equity
-144.8%
Return on invested capital
-150%
Return on capital employed
-87.3%
Return on sales
-87.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STXS stock price
How has the Stereotaxis stock price performed over time
Intraday
-1.28%
1 week
-0.77%
1 month
-0.77%
1 year
28.33%
YTD
10%
QTD
-5.64%
Financial performance
How have Stereotaxis's revenue and profit performed over time
Revenue
$23.75M
Gross profit
$14.08M
Operating income
-$21.71M
Net income
-$20.75M
Gross margin
59.3%
Net margin
-87.4%
STXS's operating margin is down by 32% YoY and by 18% from the previous quarter
Stereotaxis's net margin has decreased by 32% YoY and by 19% from the previous quarter
STXS's revenue is down by 19% YoY and by 12% from the previous quarter
Stereotaxis's gross profit has decreased by 17% YoY and by 6% from the previous quarter
Growth
What is Stereotaxis's growth rate over time
Valuation
What is Stereotaxis stock price valuation
P/E
N/A
P/B
14.01
P/S
6.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.45
The EPS has grown by 3.7% YoY
STXS's equity is down by 47% year-on-year and by 22% since the previous quarter
STXS's P/B is 42% above its 5-year quarterly average of 10.0 and 30% above its last 4 quarters average of 10.9
The stock's price to sales (P/S) is 25% less than its 5-year quarterly average of 9.3 but 14% more than its last 4 quarters average of 6.1
STXS's revenue is down by 19% YoY and by 12% from the previous quarter
Efficiency
How efficient is Stereotaxis business performance
STXS's return on invested capital has dropped by 94% year-on-year and by 8% since the previous quarter
Stereotaxis's return on equity has shrunk by 73% YoY and by 21% QoQ
Stereotaxis's ROA has decreased by 38% YoY and by 12% from the previous quarter
The ROS has contracted by 32% YoY and by 19% from the previous quarter
Dividends
What is STXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STXS.
Financial health
How did Stereotaxis financials performed over time
The company's total assets is 87% higher than its total liabilities
STXS's quick ratio is down by 31% YoY and by 16% QoQ
The company's total assets fell by 25% YoY and by 9% QoQ
Stereotaxis's debt is 53% less than its equity
STXS's debt to equity has soared by 74% year-on-year and by 27% since the previous quarter
STXS's equity is down by 47% year-on-year and by 22% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.